Conversion of Evidence and Applied Research on Intermittent Catheterization After Radical Hysterectomy

NCT ID: NCT06529107

Last Updated: 2024-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators summarize the existing best evidence of intermittent catheterization in patients after radical cervical cancer surgery from the perspective of clinical translation of evidence through systematic search, evaluation and evidence integration, construct a nursing protocol of intermittent catheterization for patients after radical cervical cancer surgery based on the best evidence combined with the clinical context, and explore the clinical application effect of the above nursing protocol. It will provide a reference basis for the development of the standardization and management of intermittent catheterization for postoperative patients with cervical cancer in China, as well as the development of guidelines for intermittent catheterization after radical cervical cancer surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intermittent Catheterization Conversion of Evidence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A best evidence-based protocol for intermittent catheterization

Group Type EXPERIMENTAL

intermittent catheterization protocol based on the best evidence

Intervention Type BEHAVIORAL

A best evidence-based protocol for intermittent catheterization after radical cervical cancer surgery

Routine intermittent catheterization care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intermittent catheterization protocol based on the best evidence

A best evidence-based protocol for intermittent catheterization after radical cervical cancer surgery

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≧ 18 years old
* Radical cervical cancer surgery and intermittent catheterization were performed at the Institute's hospital
* Patients or their family members can operate a smartphone
* No cognitive or psychiatric disorders, and can communicate effectively

Exclusion Criteria

* People with serious heart, brain, lung and other important organ diseases
* People with water, electrolyte, acid-base balance disorders at the beginning of intermittent catheterization
* People with previous serious renal diseases, bladder and urethra surgery
* People with urinary tract infections
* People who did not complete all interventions or data collection
* People who voluntarily withdrew from the study or died during the study period;
* Refuse to participate in this study
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

West China Second University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lu Xing

deputy head nurse

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

West China Second University Hospital, Sichuan University

Chengdu, Sichuan, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lu Xing

Role: CONTACT

+8619827473462

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lu Xing

Role: primary

+8619827473462

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023203

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.